<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula</h1>
  <ul>
<li>Pfizer Disclosure Notice The information contained in this release is as of September 8, 2025.</li>
<li>at 1-800-438-1985 or www.pfizersafetyreporting.com.</li>
<li>For 175 years, we have worked to make a difference for all who rely on us.</li>
<li>INDICATION AND IMPORTANT SAFETY INFORMATION INDICATION COMIRNATY (COVID-19 VACCINE, mRNA) is a vaccine to protect against coronavirus disease 2019 (COVID-19).</li>
<li>You should review the risks and uncertainties described under the heading "Risk Factors" in BioNTech's Report on Form 6-K for the period ended June 30, 2025, and in subsequent filings made by BioNTech with the SEC, which</li>
<li>Prior to receiving the LP.8.1-adapted COVID-19 vaccine 2025-2026 Formula, all participants had received the KP.2-adapted COVID-19 vaccine at least six months prior to enrollment and had not received any other COVID-19 va</li>
<li>A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in its subsequent reports on Form 10-Q, including in the sections there</li>
</ul>
<p><a href="https://finance.yahoo.com/news/pfizer-biontech-announce-topline-data-104500046.html">Source</a> · 2025-09-08T10:45:00+00:00</p>
</body>
</html>